SEC Form EFFECT filed by AgroFresh Solutions Inc.
$AGFS
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 6, 2023 |
| Accession Number: | 0001140361-23-015215 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 6, 2023 |
| Accession Number: | 0001140361-23-015215 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/10/2022 | Buy → Neutral | ROTH Capital |
ROTH Capital downgraded AgroFresh Solutions from Buy to Neutral
4 - AgroFresh Solutions, Inc. (0001592016) (Issuer)
4 - AgroFresh Solutions, Inc. (0001592016) (Issuer)
4 - AgroFresh Solutions, Inc. (0001592016) (Issuer)
15-12G - AgroFresh Solutions, Inc. (0001592016) (Filer)
EFFECT - AgroFresh Solutions, Inc. (0001592016) (Filer)
EFFECT - AgroFresh Solutions, Inc. (0001592016) (Filer)
MORRISVILLE, N.C., Dec. 16, 2021 /PRNewswire/ -- TARGAN Inc., a biotechnology systems company transforming animal protein production by bringing individualized care technologies to the poultry, swine, and aquaculture markets, announces the appointment of Mr. Clinton A. Lewis, Jr. to its board of directors. TARGAN, a biotechnology systems company announces the appointment of Mr. Clinton A. Lewis, Jr. to its Board of DirectorsClinton A. Lewis, Jr., has over 30 years of commercial, general management and senior leadership experience across the life sciences, pharmaceutical, veter
PHILADELPHIA, April 12, 2021 (GLOBE NEWSWIRE) -- AgroFresh Solutions, Inc. (NASDAQ:AGFS) (the "Company"), a global leader in produce freshness solutions, today announced that Clinton A. Lewis Jr. has been appointed as Chief Executive Officer and to the Company's Board of Directors, effective immediately. Mr. Lewis succeeds Jordi Ferre as Chief Executive Officer, who is expected to work with Mr. Lewis and the rest of the team in the coming weeks to ensure a smooth transition.Mr. Lewis brings 30-plus years of experience in the life sciences space, serving in a number of national and international leadership roles at Pfizer and Zoetis, the world's largest animal health company. Mr. Lewis was